placebo + paroxetine

This is a combination of a placebo (an inert substance with no active pharmacological effect) and paroxetine, a selective serotonin reuptake inhibitor (SSRI) antidepressant. Paroxetine increases serotonin levels in the brain by inhibiting its reuptake into presynaptic neurons, thereby improving mood and anxiety symptoms. It is used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, panic disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), and vasomotor symptoms associated with menopause[1][2][3][4][5]. The combination "placebo + paroxetine" typically refers to an arm in clinical trials where one group receives paroxetine while another receives placebo for comparison; it is not an approved or marketed fixed-dose pharmaceutical product.